PACS GROUP INC (PACS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PACS - US69380Q1076 - Common Stock
34.79 USD
+1.41 (+4.22%)
34.79 USD
0 (0%)
Overall PACS gets a fundamental rating of 3 out of 10. We evaluated PACS against 100 industry peers in the Health Care Providers & Services industry. PACS may be in some trouble as it scores bad on both profitability and health. PACS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year PACS was profitable.
1.2 Ratios
With a Return On Assets value of 0.99%, PACS perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
PACS has a Return On Equity of 6.40%. This is in the better half of the industry: PACS outperforms 62.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.75%, PACS is in line with its industry, outperforming 43.00% of the companies in the same industry.
PACS had an Average Return On Invested Capital over the past 3 years of 4.48%. This is below the industry average of 9.44%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.99% | ||
| ROE | 6.4% | ||
| ROIC | 1.75% |
ROA(3y)3.46%
ROA(5y)N/A
ROE(3y)120.58%
ROE(5y)N/A
ROIC(3y)4.48%
ROIC(5y)N/A
1.3 Margins
PACS has a Profit Margin (1.36%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of PACS has declined.
With a Operating Margin value of 3.01%, PACS perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
In the last couple of years the Operating Margin of PACS has declined.
PACS has a Gross Margin (19.38%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of PACS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.01% | ||
| PM (TTM) | 1.36% | ||
| GM | 19.38% |
OM growth 3Y-25.04%
OM growth 5YN/A
PM growth 3Y-30.78%
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PACS is destroying value.
PACS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PACS has an improved debt to assets ratio.
2.2 Solvency
PACS has an Altman-Z score of 1.51. This is a bad value and indicates that PACS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PACS (1.51) is worse than 64.00% of its industry peers.
PACS has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
PACS's Debt to Equity ratio of 0.43 is fine compared to the rest of the industry. PACS outperforms 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.51 |
ROIC/WACC0.2
WACC8.63%
2.3 Liquidity
PACS has a Current Ratio of 0.94. This is a bad value and indicates that PACS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.94, PACS is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
PACS has a Quick Ratio of 0.94. This is a bad value and indicates that PACS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, PACS is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for PACS have decreased strongly by -50.86% in the last year.
PACS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.97% yearly.
PACS shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.44%.
PACS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.91% yearly.
EPS 1Y (TTM)-50.86%
EPS 3Y4.97%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)31.44%
Revenue growth 3Y51.91%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 16.89% on average over the next years. This is quite good.
PACS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.68% yearly.
EPS Next Y31.94%
EPS Next 2Y20.95%
EPS Next 3Y16.89%
EPS Next 5YN/A
Revenue Next Year35.11%
Revenue Next 2Y21.05%
Revenue Next 3Y16.68%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 91.55, which means the current valuation is very expensive for PACS.
The rest of the industry has a similar Price/Earnings ratio as PACS.
When comparing the Price/Earnings ratio of PACS to the average of the S&P500 Index (26.54), we can say PACS is valued expensively.
A Price/Forward Earnings ratio of 16.19 indicates a correct valuation of PACS.
Based on the Price/Forward Earnings ratio, PACS is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, PACS is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.55 | ||
| Fwd PE | 16.19 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PACS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 33.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PACS does not grow enough to justify the current Price/Earnings ratio.
PACS's earnings are expected to grow with 16.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.87
PEG (5Y)N/A
EPS Next 2Y20.95%
EPS Next 3Y16.89%
5. Dividend
5.1 Amount
PACS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.79
+1.41 (+4.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners28.44%
Inst Owner Change-1.39%
Ins Owners70.49%
Ins Owner Change-0.16%
Market Cap5.45B
Revenue(TTM)4.09B
Net Income(TTM)55.76M
Analysts83.64
Price Target31.37 (-9.83%)
Short Float %7.52%
Short Ratio2.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.99%
Min EPS beat(2)8.66%
Max EPS beat(2)13.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.55%
Min Revenue beat(2)13.26%
Max Revenue beat(2)13.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.5%
PT rev (3m)-6.82%
EPS NQ rev (1m)-1.24%
EPS NQ rev (3m)-1.24%
EPS NY rev (1m)17.92%
EPS NY rev (3m)17.92%
Revenue NQ rev (1m)14.75%
Revenue NQ rev (3m)14.75%
Revenue NY rev (1m)15.53%
Revenue NY rev (3m)15.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.55 | ||
| Fwd PE | 16.19 | ||
| P/S | 1.33 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.25 | ||
| P/tB | 6.78 | ||
| EV/EBITDA | 33.03 |
EPS(TTM)0.38
EY1.09%
EPS(NY)2.15
Fwd EY6.18%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS26.11
BVpS5.56
TBVpS5.13
PEG (NY)2.87
PEG (5Y)N/A
Graham Number6.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.99% | ||
| ROE | 6.4% | ||
| ROCE | 2.78% | ||
| ROIC | 1.75% | ||
| ROICexc | 1.91% | ||
| ROICexgc | 1.94% | ||
| OM | 3.01% | ||
| PM (TTM) | 1.36% | ||
| GM | 19.38% | ||
| FCFM | N/A |
ROA(3y)3.46%
ROA(5y)N/A
ROE(3y)120.58%
ROE(5y)N/A
ROIC(3y)4.48%
ROIC(5y)N/A
ROICexc(3y)4.61%
ROICexc(5y)N/A
ROICexgc(3y)4.74%
ROICexgc(5y)N/A
ROCE(3y)7.09%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.04%
OM growth 5YN/A
PM growth 3Y-30.78%
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.28 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | 1.51 |
F-ScoreN/A
WACC8.63%
ROIC/WACC0.2
Cap/Depr(3y)147.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.35%
Cap/Sales(5y)N/A
Profit Quality(3y)200.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.86%
EPS 3Y4.97%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y31.94%
EPS Next 2Y20.95%
EPS Next 3Y16.89%
EPS Next 5YN/A
Revenue 1Y (TTM)31.44%
Revenue growth 3Y51.91%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year35.11%
Revenue Next 2Y21.05%
Revenue Next 3Y16.68%
Revenue Next 5YN/A
EBIT growth 1Y-40.77%
EBIT growth 3Y13.87%
EBIT growth 5YN/A
EBIT Next Year78.51%
EBIT Next 3Y30.29%
EBIT Next 5YN/A
FCF growth 1Y1579.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y476.7%
OCF growth 3Y85.44%
OCF growth 5YN/A
PACS GROUP INC / PACS FAQ
What is the fundamental rating for PACS stock?
ChartMill assigns a fundamental rating of 3 / 10 to PACS.
What is the valuation status for PACS stock?
ChartMill assigns a valuation rating of 2 / 10 to PACS GROUP INC (PACS). This can be considered as Overvalued.
What is the profitability of PACS stock?
PACS GROUP INC (PACS) has a profitability rating of 2 / 10.
What are the PE and PB ratios of PACS GROUP INC (PACS) stock?
The Price/Earnings (PE) ratio for PACS GROUP INC (PACS) is 91.55 and the Price/Book (PB) ratio is 6.25.
How financially healthy is PACS GROUP INC?
The financial health rating of PACS GROUP INC (PACS) is 1 / 10.